Insider Trading Activity For Cytori Therapeutics Inc (NASDAQ:CYTX)
Bank Sa Swissquote , Major Shareholder of Cytori Therapeutics Inc (NASDAQ:CYTX) reportedly Sold 100,000 shares of the company’s stock at an average price of 0.38 for a total transaction amount of $38,000.00 SEC Form
Insider Trading History For Cytori Therapeutics Inc (NASDAQ:CYTX)
On 12/19/2012 Marc H Hedrick, President, bought 10,000 with an average share price of $2.85 per share and the total transaction amounting to $28,500.00.View SEC Filing
On 12/19/2012 Lloyd H Dean, Director, bought 25,000 with an average share price of $2.85 per share and the total transaction amounting to $71,250.00.View SEC Filing
On 8/30/2013 Tommy G Thompson, Director, bought 5,000 with an average share price of $2.14 per share and the total transaction amounting to $10,700.00.View SEC Filing
On 9/3/2013 David Rickey, Director, bought 7,000 with an average share price of $2.14 per share and the total transaction amounting to $14,980.00.View SEC Filing
On 9/5/2013 David Rickey, Director, bought 2,000 with an average share price of $2.24 per share and the total transaction amounting to $4,480.00.View SEC Filing
On 9/9/2013 David Rickey, Director, bought 5,000 with an average share price of $2.31 per share and the total transaction amounting to $11,550.00.View SEC Filing
On 9/11/2013 David Rickey, Director, bought 2,000 with an average share price of $2.58 per share and the total transaction amounting to $5,160.00.View SEC Filing
Analyst Ratings History For Cytori Therapeutics Inc (NASDAQ:CYTX)
- On 6/28/2016 Roth Capital Reiterated Rating Buy with a price target of $11.00
- On 11/7/2017 B. Riley Reiterated Rating Hold
- On 1/5/2018 Maxim Group Set Price Target of rating Buy with a price target of $5.00
Recent Trading Activity for Cytori Therapeutics Inc (NASDAQ:CYTX)
Shares of Cytori Therapeutics Inc closed the previous trading session at 0.40 up +0.06 19.04% with 0.34279999136924744 shares trading hands.